Compartmentalization of pro-inflammatory cytokines in tuberculous pleurisy

被引:37
作者
Hoheisel, G
Izbicki, G
Roth, M
Chan, CHS
Leung, JCK
Reichenberger, F
Schauer, J
Perruchoud, AP
机构
[1] Univ Leipzig, Dept Internal Med 1, Med Unit 1, Div Pneumol, D-04103 Leipzig, Germany
[2] Univ Basel, Res Dept, Div Pneumol, Basel, Switzerland
[3] Univ Basel, Dept Internal Med, Div Pneumol, Basel, Switzerland
[4] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Internal Med, Pulm Unit, Hong Kong, Hong Kong
关键词
D O I
10.1016/S0954-6111(98)90025-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increased levels of interleukin-6 (IL-6) and IL-8 are found in various immunologically mediated inflammatory disorders. Concentrations of IL-6, IL-8 and the soluble form of the IL-6 receptor (sIL-6R) were determined in serum and effusion fluid of 25 patients with tuberculous pleurisy utilizing enzyme linked immunosorbent assays (EIA). Serum IL-6 levels were only slightly increased in patients with tuberculous pleurisy in comparison to controls (11.1 +/- 2.1 vs 7.3 +/- 1.0 pg ml(-1)). IL-8 could not be detected in the serum of tuberculosis patients, but it was detected in the serum of healthy controls (8.0 +/- 1.5 pg ml(-1)). In comparison to serum, IL-6 and IL-8 were found in high concentrations in pleural effusions (IL-6: 932 +/- 70 vs 11.1 +/- 2.1 pg ml(-1), P<0.0001; IL-8: 450 +/- 85 vs 0 +/- 0 pg ml(-1)). In contrast, sIL-6R concentrations were much higher in serum compared to pleural effusion levels [30477+/-1905 vs 9881 +/- 1177 pg ml(-1), P<0.0001 (mean +/- SEM)]. The authors conclude that elevated levels of IL-6 and IL-S in pleural effusions are compartmentalized at the site of active disease. The low levels of sIL-6R in the presence of high levels of IL-6 in pleural effusions, and the high levels of sIL-6R in the presence of low levels of IL-C in serum suggest that the expression or shedding of sIL-6R may be downregulated in the presence of excessive amounts of IL-6.
引用
收藏
页码:14 / 17
页数:4
相关论文
共 13 条
[1]  
ANTONY VB, 1983, ACTA CYTOL, V27, P335
[2]  
BARNES PF, 1989, J IMMUNOL, V142, P1114
[3]   CYTOKINES IN THE BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH ACTIVE PULMONARY SARCOIDOSIS [J].
GIRGIS, RE ;
BASHA, MA ;
MALIARIK, M ;
POPOVICH, J ;
IANNUZZI, MC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (01) :71-75
[4]  
HONDA M, 1992, J IMMUNOL, V148, P2175
[5]   THE BIOLOGY OF INTERLEUKIN-6 [J].
KISHIMOTO, T .
BLOOD, 1989, 74 (01) :1-10
[6]   PURIFICATION OF SOLUBLE CYTOKINE RECEPTORS FROM NORMAL HUMAN URINE BY LIGAND-AFFINITY AND IMMUNOAFFINITY CHROMATOGRAPHY [J].
NOVICK, D ;
ENGELMANN, H ;
WALLACH, D ;
LEITNER, O ;
REVEL, M ;
RUBINSTEIN, M .
JOURNAL OF CHROMATOGRAPHY, 1990, 510 :331-337
[7]  
PETTERSSON T, 1981, ACTA MED SCAND, V210, P129
[8]   TUBERCULOUS PLEURAL EFFUSIONS - EVIDENCE FOR SELECTIVE PRESENCE OF PPD-SPECIFIC LYMPHOCYTES-T AT SITE OF INFLAMMATION IN THE EARLY PHASE OF THE INFECTION [J].
ROSSI, GA ;
BALBI, B ;
MANCA, F .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (03) :575-579
[9]   INTRACELLULAR INTERLEUKIN-6 MEDIATES PLATELET-DERIVED GROWTH FACTOR-INDUCED PROLIFERATION OF NONTRANSFORMED CELLS [J].
ROTH, M ;
NAUCK, M ;
TAMM, M ;
PERRUCHOUD, AP ;
ZIESCHE, R ;
BLOCK, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1312-1316
[10]  
STRIETER RM, 1994, J LAB CLIN MED, V123, P183